Clinical Trials Logo

Membranes Artificial clinical trials

View clinical trials related to Membranes Artificial.

Filter by:
  • None
  • Page 1

NCT ID: NCT04462614 Not yet recruiting - Prospective Studies Clinical Trials

Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA

REMARK
Start date: August 2020
Phase: N/A
Study type: Interventional

Use HeprAN ™ membrane (coated with heparin) should be allow the success of dialysis sessions, with adequate dialysis parameters, in patients treated by long-term anticoagulation with VKA, without addition of heparin perdialytic. Less use of heparin (UFH or LMWH) during hemodialysis session should be allow a decrease of bleedings (moderate or major) and blood transfusions for hemodialysed patients with HeprAN ™ membrane and treated by long-term anticoagulation with VKA